SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-19-000500
Filing Date
2019-02-14
Accepted
2019-02-14 21:55:46
Documents
1
Period of Report
2019-02-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form407216001_02142019.html 4  
1 OWNERSHIP DOCUMENT form407216001_02142019.xml 4 15737
  Complete submission text file 0000921895-19-000500.txt   18484
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address
COUCHMAN JONATHAN (Reporting) CIK: 0001265094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19609679

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020 212.729.4962
Xstelos Corp. (Reporting) CIK: 0001571659 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19609681

Mailing Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE, SUITE 2260 NEW YORK NY 10020 (212) 729-4962
Couchman Family Fund (Reporting) CIK: 0001737322 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36435 | Film No.: 19609680